Japanese firm Eisai Co., Ltd. and US based Wren Therapeutics Ltd. have announced that the companies have entered into an...
OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...
New Zealand's Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, has ident...
Hong Kong-based Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecu...
Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...
Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the ...
CStone Pharmaceuticals has announced a licensing agreement with LegoChem Biosciences, Inc., (LCB) for the development an...
ASLAN Pharmaceuticals, clinical-stage immunology focused biopharmaceutical company developing innovative treatments to t...
Prestige BioPharma Ltd. on 13 Oct 2020 announced that the European Medicines Agency (EMA) Orphan Drug Commission (C...
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...
The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...
Marinomed Biotech AG, a Vienna-based biopharmaceutical company, develops groundbreaking treatment for autoimmune gastrit...
South Korea based Standigm Inc., an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, ...
Excelra, a global data science and data analytics company headquartered in India, has announced its collaboration with S...
Eisai Co., Ltd. announced on 10 June 2020 that it has committed the equivalent of 1 million USD in aid towards various a...
India-based Sun Pharmaceutical Industries Ltd (Sun Pharma) has received Indian regulatory approval to start clinical tri...
Roche, a global leading provider of pharmaceuticals and cancer treatments, today announced that the Health Sciences Auth...
